CRA analyzed market definition in antitrust litigation concerning a product in the non-opioid pain category. In defining the relevant antitrust market, our work accounted for indicators of competition among branded pharmaceutical products, including market positioning, factors driving physician choice, development of new approved indications, and competition for formulary listing.
IP Literature Watch: August 2022
Among the pieces featured in this month’s IP Literature Watch are a chapter exploring EU copyright framework relevant for the digitization of cultural...